Nie Xiaoqi, Deputy General Manager of Minhai Biotechnology, has been honored as a 2025 Beijing Model Worker!

Release date:

2025-04-30

Author:

Source:


Abstract

On April 29, the Beijing Municipal Conference on Commending Model Workers, Advanced Workers, and Exemplary Collectives was solemnly held at the Beijing Convention Center. With approval from the CPC Beijing Municipal Committee and the Beijing Municipal People’s Government, Nie Xiaoqi, Deputy General Manager of Minhai Biotechnology, was awarded the honorary title of “Beijing Model Worker for 2025.” This year’s commendation placed particular emphasis on recognizing knowledge-based, skill‑driven, and innovation‑oriented workers, focusing on the capital’s major strategic priorities and key industries. Thanks to his outstanding contributions in vaccine production and quality management, Mr. Nie emerged as one of the distinguished representatives honored in the pharmaceutical and healthcare sector. For many years, Mr. Nie has been deeply committed to vaccine industrialization and quality assurance, successively holding positions in production management…

On April 29, the Beijing Municipal Conference on Commending Model Workers, Advanced Workers, and Model Collectives was solemnly held at the Beijing Convention Center. With the approval of the CPC Beijing Municipal Committee and the People’s Government of Beijing Municipality, Minhai Organism Deputy General Manager Nie Xiaoqi was awarded Beijing Model Worker of 2025 “Honor” Title.

This time Model worker The recognition honors workers who are knowledgeable, skilled, and innovative, with a focus on the capital’s major strategies and key industries. Thanks to his outstanding contributions in vaccine production, quality management, and related fields, Nie Xiaoqi has become a prominent figure in the pharmaceutical sector. Outstanding representatives recognized in the health sector One of them

Nie Xiaoqi has long been dedicated to vaccine industrialization and quality management, and has successively… To serve as Production Management Manager Quality Management Officer. Successfully spearheaded acellular pertussis–diphtheria–tetanus vaccine Haemophilus influenzae type b conjugate vaccine 23-valent pneumococcal polysaccharide vaccine, 13-valent pneumococcal conjugate vaccine, lyophilized human rabies vaccine, live attenuated varicella vaccine, and others. Many The successful launch of this product has firmly reinforced the company’s leading position in the domestic vaccine market. Under the leadership of Nie Xiaoqi, the team has studied international quality management principles and requirements, continuously enhanced the company’s quality management capabilities, and steadily optimized its quality management system, thereby ensuring that the company’s quality system has been certified. Multiple items International certification ensures alignment with global standards.

Kangtai Minhai As one of China’s leading vaccine companies, it has consistently adhered to… With the mission of “creating better vaccines to benefit human health,” in 3 Over more than a decade of development, the company has earned widespread recognition and trust from all sectors of society through its deep R&D foundation, rigorous quality management, and strong sense of social responsibility. Consistently aligned with key national initiatives—such as “enhancing independent innovation capabilities, building an innovative nation, and implementing a strategy to strengthen the country through talent”—the company places great emphasis on cultivating a talent pipeline that integrates industry, academia, and research, and has established high‑level R&D platforms including a Postdoctoral Research Station and an Academician–Expert Workstation. Continuously optimize the talent development platform and training system. , has been awarded numerous honors, including Beijing Model Worker, the Capital Labor Medal, the New National Gateway Leading Talent Award, and the Outstanding Science and Technology Worker Award.

This time, the company’s senior executives have been honored as Beijing Model Workers, a significant achievement of Kangtai Group’s talent development system, and also… A concentrated embodiment of the corporate culture’s core principle: “Work diligently and conduct oneself with integrity.” Including Nie Xiaoqi, Kangtai Minhai also boasts a large contingent of knowledgeable, skilled, and responsible employees who shine in every stage—research and development, production, quality control, and more. Looking ahead, Kangtai Minhai will continue to uphold the spirit of model workers, the spirit of labor, and the spirit of craftsmanship. Unwaveringly committed to exploring the cutting edge of vaccine technology. , contributing further to the high-quality development of China’s biopharmaceutical industry. We are working tirelessly to prevent the spread of infectious diseases and safeguard public health!

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09